Ascorbic acid-induced regression of amyloidosis in experimental animals

Area of Science:

• Biochemistry
• Immunology
• Pharmacology

Background:

• Amyloidosis is characterized by the deposition of amyloid proteins.
• Amyloid-degrading activity in serum is reduced in amyloidotic conditions.
• Ascorbic acid (vitamin C) has shown potential in vitro to restore this activity.

Purpose of the Study:

• To investigate the in vivo effect of ascorbic acid on amyloid deposition and degradation.
• To evaluate the dose-dependency of ascorbic acid's effect.
• To compare ascorbic acid's efficacy with colchicine in managing amyloidosis.

Main Methods:

• Casein-induced murine amyloidosis model was used.
• Oral administration of ascorbic acid was performed.
• Histopathological examination of splenic tissue was conducted.
• Serum amyloid-degrading activity was assessed.

Main Results:

• Ascorbic acid treatment significantly decreased amyloid deposition in splenic tissue.
• The effect of ascorbic acid was found to be dose-dependent.
• Ascorbic acid partially restored the reduced amyloid-degrading activity of serum in treated mice.
• Colchicine inhibited amyloid synthesis during induction but not post-induction.

Conclusions:

• Ascorbic acid demonstrates efficacy in accelerating amyloid degradation in a murine model.
• Oral administration of ascorbic acid is a potential therapeutic strategy for amyloidosis.
• Further research into ascorbic acid's mechanism in amyloidosis is warranted.